Long-term prognosis of hemangioblastomas of the central nervous system: clinical and immunohistochemical study in relation to recurrence.

Miyagami, Mitsusuke; Katayama, Yoichi

Miyagami, Mitsusuke; Katayama, Yoichi.

Affiliation

Miyagami M; Department of Neurosurgery, Nihon University Surugadai Hospital, 1-8-13 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-8309, Japan. nougeka@med.nihon-u.ac.jp

Brain Tumor Pathol ; 21(2): 75-82, 2004.

Article in En | MEDLINE | ID: mdl-15700837

Subject(s)

Central Nervous System Neoplasms/pathology; Hemangioblastoma/pathology; Neoplasm Recurrence, Local/pathology; Adolescent; Adult; Central Nervous System Neoplasms/metabolism; Central Nervous System Neoplasms/therapy; Child; Female; Hemangioblastoma/metabolism; Hemangioblastoma/therapy; Humans; Immunohistochemistry; Ki-67 Antigen/metabolism; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local/metabolism; Neoplasm Recurrence, Local/therapy; Prognosis; Treatment Outcome; Tumor Suppressor Protein p53/metabolism; Vascular Endothelial Growth Factor A/metabolism; von Hippel-Lindau Disease/complications

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Central Nervous System Neoplasms / Hemangioblastoma / Neoplasm Recurrence, Local Type of study: Prognostic_studies Limits: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Language: En Journal: Brain Tumor Pathol Journal subject: CEREBRO / NEOPLASIAS / PATOLOGIA Year: 2004 Type: Article Affiliation country: Japan

Search on Google

XML

PubMed Links